<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ups J Med Sci</journal-id>
      <journal-id journal-id-type="publisher-id">UPS</journal-id>
      <journal-title-group>
        <journal-title>Upsala Journal of Medical Sciences</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0300-9734</issn>
      <issn pub-type="epub">2000-1967</issn>
      <publisher>
        <publisher-name>Informa Healthcare</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">20731531</article-id>
      <article-id pub-id-type="pmc">2971487</article-id>
      <article-id pub-id-type="doi">10.3109/03009734.2010.486908</article-id>
      <article-id pub-id-type="publisher-id">UPS_A_486908_O</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Short Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A patient with Graves' disease who survived despite developing thyroid storm and lactic acidosis</article-title>
      </title-group>
      <contrib-group>
        <contrib id="a1" contrib-type="author" corresp="no">
          <name>
            <surname>Yoshino</surname>
            <given-names>Tetsuhiro</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib id="a2" contrib-type="author" corresp="no">
          <name>
            <surname>Kawano</surname>
            <given-names>Daisuke</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a3" contrib-type="author" corresp="no">
          <name>
            <surname>Azuhata</surname>
            <given-names>Takeo</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a4" contrib-type="author" corresp="no">
          <name>
            <surname>Kuwana</surname>
            <given-names>Tsukasa</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a5" contrib-type="author" corresp="no">
          <name>
            <surname>Kogawa</surname>
            <given-names>Rikimaru</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a6" contrib-type="author" corresp="no">
          <name>
            <surname>Sakurai</surname>
            <given-names>Atsushi</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a7" contrib-type="author" corresp="no">
          <name>
            <surname>Tanjoh</surname>
            <given-names>Katsuhisa</given-names>
          </name>
          <xref ref-type="aff" rid="AF0002">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib id="a8" contrib-type="author" corresp="yes">
          <name>
            <surname>Yanagawa</surname>
            <given-names>Tatsuo</given-names>
          </name>
          <xref ref-type="aff" rid="AF0001">
            <sup>1</sup>
          </xref>
        </contrib>
        <aff id="AF0001">
          <sup>1</sup>
          <institution>Department of Internal Medicine, Nerima General Hospital, Asahigaoka, Nerima-ku, Tokyo,</institution>
          <country>Japan</country>
        </aff>
        <aff id="AF0002">
          <sup>2</sup>
          <institution>Division of Emergency and Critical Care Medicine, Department of Acute Medicine, Nihon University School of Medicine, Oyaguchi Kamimachi, Itabashi-ku, Tokyo,</institution>
          <country>Japan</country>
        </aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">Correspondence: Tatsuo Yanagawa, MD, Department of Medicine, Nerima General Hospital, 1-24-1, Asahigaoka, Nerima-ku, Tokyo 176-8530, Japan. <fax>+81-3-5988-2250</fax>. <email>tyana-mj@xj9.so-net.ne.jp</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>10</month>
        <year>2010</year>
      </pub-date>
      <volume>115</volume>
      <issue>4</issue>
      <fpage>282</fpage>
      <lpage>286</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>2</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>4</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Upsala Medical Society</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>A 56-year-old woman with Graves' disease presented with the complaints of diarrhea and palpitations. Physical examination and laboratory data revealed hypothermia and signs of mild hyperthyroidism, heart failure, hepatic dysfunction with jaundice, hypoglycemia, and lactic acidosis. The patient was diagnosed as having developed the complication of thyroid storm in the absence of marked elevation of the thyroid hormone levels, because of the potential hepatic and cardiac dysfunctions caused by heavy alcohol drinking. A year later, after successful treatment, the patient remains well without any clinical evidence of heart failure or hepatic dysfunction. Thyroid storm associated with lactic acidosis and hypothermia is a serious condition and has rarely been reported. Prompt treatment is essential even if the serum thyroid hormone levels are not markedly elevated. We present a report about this patient, as her life could eventually be saved.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Graves' disease</kwd>
        <kwd>hypoglycemia</kwd>
        <kwd>lactic acidosis</kwd>
        <kwd>thyroid storm</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="" id="intro">
      <title>Introduction</title>
      <p>Thyroid storm is a serious complication of thyrotoxicosis, with a high mortality, that is diagnosed based on clinical examination (<xref ref-type="bibr" rid="CIT0001 CIT0002">1,2</xref>). The severity of thyroid storm is not necessarily correlated with the thyroid hormone levels, although the exact underlying mechanisms explaining the severity are unknown (<xref ref-type="bibr" rid="CIT0001 CIT0002">1,2</xref>). We encountered a patient who developed thyroid storm associated with lactic acidosis and hypothermia in the absence of marked elevation of the serum thyroid hormone levels. Thyroid storm associated with lactic acidosis and hypothermia is a serious condition and has rarely been reported. The case is discussed with references to the literature.</p>
    </sec>
    <sec sec-type="" id="ss2">
      <title>Case report</title>
      <p>The patient was a 56-year-old woman, with a personal history of habitually drinking 100 g or more of alcohol daily from 20 to 53 years of age and smoking 0.5 pack a day for 36 years. Past and family history was not contributory.</p>
      <sec id="ss3">
        <title>Present illness</title>
        <p>A 56-year-old woman was diagnosed as having Graves' disease (GD) at the age of 49, and was started on treatment with methimazole (MMI). After the thyroid hormone levels returned to the normal range, the patient discontinued her visits to the hospital. When she was 53 years old, she visited our hospital again with tachycardia and abdominal distension. Laboratory examination revealed evidence of mild hyperthyroidism (free thyroxine (fT4), 2.46 ng/dL) and hepatic dysfunction (total bilirubin (T.Bil), 0.5 mg/dL; aspartate aminotransferase (AST), 582 IU/L; and alanine aminotransferase (ALT), 323 IU/L). Abdominal Computed Tomography (CT) revealed ascites; however, there were no clear signs of liver cirrhosis. Based on the diffuse wall motion abnormality in the heart observed on echocardiography, the patient was diagnosed as having dilated cardiomyopathy (ejection fraction (EF), 38%). In addition to hyperthyroidism, alcohol was considered as one of the causes of the cardiomyopathy, in view of the history of heavy alcohol drinking. Treatment with iodine potassium (KI), MMI, propranolol (30 mg daily) and furosemide was initiated. The patient showed clinical improvement within a week; however, she discontinued all treatment after being discharged from the hospital.</p>
        <p>In July 2008, she visited our hospital again with the complaints of palpitations and abdominal distension. Based on the clinical and laboratory data (serum free tri-iodothyronine (fT3), 12.7 pg/dL; fT4, 5.09 ng/dL), the patient was diagnosed as having developed recurrence of GD and congestive heart failure. Treatment was initiated on an outpatient basis with MMI (15 mg), furosemide, and spironolactone. One month later, the serum fT4 decreased to 0.4 ng/dL, suggestive of hypothyroidism. MMI was discontinued, and 2 weeks after the drug withdrawal the patient visited our hospital with the complaints of diarrhea and palpitations. Clinical and laboratory examination revealed evidence of mild hyperthyroidism again and of hepatic dysfunction with jaundice. Hepatic congestion secondary to hyperthyroidism and heart failure was diagnosed, and treatment with MMI (20 mg/day), metoprolol (20 mg/day), spironolactone, and furosemide was initiated. However, since the patient had persistent dyspnea for several hours after the start of the treatment, she was examined at the department of emergency medicine of our hospital and hospitalized.</p>
      </sec>
      <sec id="ss4">
        <title>Condition at the time of admission</title>
        <p>Glasgow coma scale score for consciousness, 15 (E4V5M6); blood pressure, 107/80 mmHg; pulse, 134 beats/min; body temperature, 34.5&#xB0;C; respiratory rate, 30/min; oxygen saturation on room air, 95%. Physical examination revealed abdominal distention caused by ascites; however, there were no other abnormal findings, including edema of the legs.</p>
      </sec>
      <sec id="ss5">
        <title>Chest X-ray</title>
        <p>Cardiothoracic ratio, 61%; enlargement of the left ventricle.</p>
      </sec>
      <sec id="ss6">
        <title>Electrocardiogram</title>
        <p>Pulse rate, 134/min; atrial fibrillation +.</p>
      </sec>
      <sec id="ss7">
        <title>Echocardiography</title>
        <p>Left atrial dimension, 42 mm; mitral regurgitation, moderate; EF, 48%; left ventricular dimension&#x2013;diastole, 41 mm; left ventricular dimension&#x2013;systole, 31 mm; tricuspid regurgitation, trivial; estimated pulmonary arterial pressure, 40 mmHg; right atrial diameter, 44 mm; right ventricular diameter, 37 mm; inferior vena cava diameter, 23 mm; respiratory fluctuations, absent.</p>
      </sec>
      <sec id="ss8">
        <title>Blood examination findings on admission (<xref ref-type="table" rid="T1">Table I</xref>)</title>
        <p>T.Bil, 2.5 mg/dL; AST, 347 IU/L; ALT, 278 U/L, suggestive of hepatopathy with jaundice. Serum fT3, 7.80 pg/dL and serum fT4, 3.05 ng/dL, suggestive of hyperthyroidism. Serum N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), 971 pg/mL, suggestive of heart failure. Arterial blood gas analysis (in ambient air) revealed a pH of 7.404, PCO<sub>2</sub> of 10.0 mmHg, PO<sub>2</sub> of 137.5 mmHg, HCO<sub>3</sub> of 5.0 mEq/L, and Base Excess (BE) of &#x2212;14.5, indicative of metabolic acidosis with respiratory alkalosis.</p>
        <table-wrap id="T1" orientation="portrait" position="float">
          <label>Table I.</label>
          <caption>
            <p>Laboratory Fidings.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th align="left" rowspan="1" colspan="1">Variable</th>
                <th align="left" rowspan="1" colspan="1">On admission</th>
                <th align="left" rowspan="1" colspan="1">16 hours later</th>
                <th align="left" rowspan="1" colspan="1">Reference range</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" rowspan="1" colspan="1">White blood cells (/&#x3BC;L)</td>
                <td align="char" char="." rowspan="1" colspan="1">8,700</td>
                <td align="char" char="." rowspan="1" colspan="1">21,300</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">3,500&#x2013;8,500</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Hemoglobin (g/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">13.5</td>
                <td align="char" char="." rowspan="1" colspan="1">11.8</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">11.5&#x2013;15.0</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Platelets (/&#x3BC;L)</td>
                <td align="char" char="." rowspan="1" colspan="1">224,000</td>
                <td align="char" char="." rowspan="1" colspan="1">195,000</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">150,000&#x2013;350,000</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">C-reactive protein (mg/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">1.1</td>
                <td align="char" char="." rowspan="1" colspan="1">1.3</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">0&#x2013;0.35</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Albumin (g/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">3.9</td>
                <td align="char" char="." rowspan="1" colspan="1">3.5</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">3.9&#x2013;5.2</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Total bilirubin (mg/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">2.5</td>
                <td align="char" char="." rowspan="1" colspan="1">4.2</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">0.4&#x2013;1.3</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Creatine phosphokinase (IU/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">657</td>
                <td align="char" char="." rowspan="1" colspan="1">2,169</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">50&#x2013;170</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Lactate dehydrogenase (U/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">562</td>
                <td align="char" char="." rowspan="1" colspan="1">4,325</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">120&#x2013;220</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Aspartate aminotransferase (U/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">347</td>
                <td align="char" char="." rowspan="1" colspan="1">2,751</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">10&#x2013;35</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alanine aminotransferase (U/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">278</td>
                <td align="char" char="." rowspan="1" colspan="1">1,036</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">5&#x2013;40</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Alkaline phosphatase (U/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">981</td>
                <td align="char" char="." rowspan="1" colspan="1">791</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">100&#x2013;320</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">&#x3B3;-Glutamyltransferase (IU/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">92</td>
                <td align="char" char="." rowspan="1" colspan="1">72</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">5&#x2013;40</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Serum creatinine (mg/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">0.74</td>
                <td align="char" char="." rowspan="1" colspan="1">1.77</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">0.4&#x2013;0.8</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Urea nitrogen (mg/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">17</td>
                <td align="char" char="." rowspan="1" colspan="1">25</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">8&#x2013;20</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Plasma glucose (mg/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">142</td>
                <td align="char" char="." rowspan="1" colspan="1">42</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">70&#x2013;110</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Free tri-iodothyronine (pg/mL)</td>
                <td align="char" char="." rowspan="1" colspan="1">7.80</td>
                <td align="char" char="." rowspan="1" colspan="1">4.03</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">2.0&#x2013;4.5</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Free thyroxine (ng/dL)</td>
                <td align="char" char="." rowspan="1" colspan="1">3.05</td>
                <td align="char" char="." rowspan="1" colspan="1">2.68</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">0.7&#x2013;1.8</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Thyroid-stimulating hormone (&#x3BC;U/mL)</td>
                <td align="char" char="." rowspan="1" colspan="1">&lt;0.05</td>
                <td align="char" char="." rowspan="1" colspan="1">&lt;0.05</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">0.3&#x2013;4.5</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Thyrotropin receptor antibody (IU/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">13.3</td>
                <td align="char" char="." rowspan="1" colspan="1"/>
                <td align="char" char="ndash" rowspan="1" colspan="1">0&#x2013;0.9</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">N-terminal pro-brain natriuretic peptide (pg/mL)</td>
                <td align="char" char="." rowspan="1" colspan="1">971</td>
                <td align="char" char="." rowspan="1" colspan="1"/>
                <td align="char" char="ndash" rowspan="1" colspan="1">0&#x2013;125</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Sodium (mmol/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">131</td>
                <td align="char" char="." rowspan="1" colspan="1">126</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">136&#x2013;145</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Potassium (mmol/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">4.5</td>
                <td align="char" char="." rowspan="1" colspan="1">5.8</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">3.6&#x2013;4.8</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Chloride (mmol/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">98</td>
                <td align="char" char="." rowspan="1" colspan="1">90</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">99&#x2013;107</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">pH</td>
                <td align="char" char="." rowspan="1" colspan="1">7.404</td>
                <td align="char" char="." rowspan="1" colspan="1">7.020</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">7.35&#x2013;7.45</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PaCO<sub>2</sub> (mmHg)</td>
                <td align="char" char="." rowspan="1" colspan="1">10.0</td>
                <td align="char" char="." rowspan="1" colspan="1">17.0</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">35&#x2013;45</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">PaO<sub>2</sub> (mmHg)</td>
                <td align="char" char="." rowspan="1" colspan="1">137.5</td>
                <td align="char" char="." rowspan="1" colspan="1">135.0</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">80&#x2013;100</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Bicarbonate (mmol/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">5.0</td>
                <td align="char" char="." rowspan="1" colspan="1">4.5</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">20&#x2013;26</td>
              </tr>
              <tr>
                <td align="left" rowspan="1" colspan="1">Base excess (mmol/L)</td>
                <td align="char" char="." rowspan="1" colspan="1">&#x2212;14.5</td>
                <td align="char" char="." rowspan="1" colspan="1">&#x2212;25.4</td>
                <td align="char" char="ndash" rowspan="1" colspan="1">&#x2212;3&#x2013;3</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="ss9">
        <title>Course after admission</title>
        <p>With the diagnosis of hyperthyroidism complicated by heart failure and metabolic acidosis, treatment was initiated with KI, MMI, furosemide, and spironolactone, in an attempt to improve the cardiohemodynamics. One dose of metoprolol (20 mg) was administered orally prior to hospitalization and then discontinued. After hospitalization, the patient's condition deteriorated, and 16 hours later she developed evidence of severe acidemia, hypoglycemia (42 mg/dL), and hepatopathy with jaundice (<xref ref-type="table" rid="T1">Table I</xref>). Signs of renal failure were also present, and the patient became delirious. On the basis of the Burch-Wartofsky score (<xref ref-type="bibr" rid="CIT0002">2</xref>), which is a widely used global scale for evaluation of the severity of thyrotoxicosis, the patient's condition was diagnosed as thyroid storm (thyrotoxicosis with delirium (20 points), jaundice (20 points), moderate heart failure (10 points), and tachycardia (20 points); a total score of 61 or more is suggestive of definite thyroid storm). The patient was transferred to the Department of Emergency and Critical Care Medicine, Nihon University. At the time of admission to this department, the serum lactate level was 27.6 mmol/L, suggestive of lactic acidosis. Treatment with sodium bicarbonate, vitamin B1, dopamine, monoammonium glycyrrhizinate, L-arginine L-glutamate, lactulose, fresh frozen plasma, human atrial natriuretic peptide, and furosemide was started, and hemodialysis was instituted. The vital signs stabilized, and thereafter the patient, who was under treatment with oral MMI, furosemide, and ursodeoxycholic acid, was transferred to our hospital again. When the thyroid function parameters normalized, she was discharged from our hospital. Echocardiography repeated while the patient was in stable condition revealed an EF of 61%, and the serum brain natriuretic peptide was approximately 20 pg/mL. Serum biochemistry examination did not reveal any abnormalities. Currently, approximately a year after discharge from the hospital, the patient is leading a normal life without any subjective symptoms.</p>
      </sec>
    </sec>
    <sec sec-type="" id="ss10">
      <title>Discussion</title>
      <p>Thyroid storm is a serious complication of thyrotoxicosis, with a high mortality, that is diagnosed based on clinical examination (<xref ref-type="bibr" rid="CIT0001 CIT0002">1,2</xref>). Our patient was diagnosed as having thyroid storm on the basis of the Burch-Wartofsky score (<xref ref-type="bibr" rid="CIT0002">2</xref>), which is a widely used global scale for evaluation of the severity of thyrotoxicosis. The salient findings in our patient were as follows: deterioration of the clinical condition without marked elevation of the serum levels of thyroid hormones, lactic acidosis, and hypothermia. There are hardly any reports of thyroid storm associated with lactic acidosis in the literature (<xref ref-type="bibr" rid="CIT0003 CIT0004 CIT0005">3&#x2013;5</xref>). Hypothermia is also uncommon in thyroid storm; however, it has been reported sometimes in the elderly (<xref ref-type="bibr" rid="CIT0002">2</xref>).</p>
      <p>The severity of thyroid storm is not necessarily correlated with the thyroid hormone levels (<xref ref-type="bibr" rid="CIT0001 CIT0002">1,2</xref>). Some factors such as sensitivity to catecholamines and advanced age have been implicated in the occurrence of thyroid storm, although the exact underlying mechanisms are unknown (<xref ref-type="bibr" rid="CIT0001 CIT0006">1,6</xref>). Our present patient also developed thyroid storm without marked elevation of the serum fT4 levels (3.05 ng/dL).</p>
      <p>Two possible etiological factors may be considered in our patient. The first is potential depression of cardiac function due to cardiomyopathy. When she developed combined left and right heart failure because of hyperthyroidism 3 years earlier, echocardiography had revealed evidence of cardiomyopathy, with an EF of 38%. When the thyroid function returned to normal, the EF increased to at least 60%, showing improvement of cardiac function; the serum brain natriuretic peptide also returned to within the normal reference range; there were no symptoms interfering with the activities of daily living. Both alcohol (<xref ref-type="bibr" rid="CIT0007">7</xref>) and hyperthyroidism were considered to be etiologically related to the development of cardiomyopathy. Hyperthyroidism may lead to persistent or reversible cardiomyopathy; however, the precise underlying mechanism is unknown (<xref ref-type="bibr" rid="CIT0008 CIT0009">8,9</xref>). In our patient, the cardiac function improved with improvement of the thyroid function, which could be explained as follows: the cardiac function may have been impaired by the alcoholic cardiomyopathy, and low cardiac output heart failure may have developed because of hyperthyroidism. The beta-blocker (metoprolol, 20 mg) administered for the treatment of tachycardia may have exacerbated the morbid condition.</p>
      <p>The second factor that could be implicated in the development of thyroid storm in our patient, which resulted in worsening of the morbid condition, was alcoholic hepatopathy. Neither the serum albumin level and platelet count, nor abdominal CT revealed any definitive evidence of liver cirrhosis, but it is considered that the patient may have had hepatopathy, because she gave a history of heavy drinking of more than 100 g of alcohol every day for more than 30 years. In the presence of hyperthyroidism, pulmonary hypertension and right heart failure frequently lead to liver congestion (<xref ref-type="bibr" rid="CIT0010">10</xref>), but it is considered that the condition progressed to the point of manifesting as jaundice because of the possible presence of alcoholic hepatopathy.</p>
      <p>In regard to the etiology of thyroid storm, it is necessary to take into consideration the involvement of potential visceral disorders, including of the heart and liver, as in the present patient, as well as the thyroid hormone levels. Chronic heart failure with subjective symptoms, uncompensated liver cirrhosis, etc. associated with hyperthyroidism may easily lead to organ failure. It remains under debate whether such a condition should be diagnosed as thyroid storm. However, besides patients with organ dysfunction caused by alcohol, several elderly, diabetic patients and hypertensive patients also have decreased cerebral blood flow and myocardial disorders (<xref ref-type="bibr" rid="CIT0011 CIT0012">11,12</xref>). When thyrotoxicosis precipitates failure of the hemodynamics in such patients, the possibility of development of thyroid storm is increased.</p>
      <p>Our present patient showed lactic acidosis. Vitamin B1 was administered, because deficiency of this vitamin is one of the risk factors for the development of lactic acidosis. Vitamin B1 is a co-factor of decarboxylase in the tricarboxylic acid cycle, and its deficiency shifts glucose metabolism from aerobic towards anaerobic. With regard to acidosis complicating thyroid storm, while many reports have shown that thyroid storm can be complicated by ketoacidosis via the insulin antagonist actions of thyroid hormones (<xref ref-type="bibr" rid="CIT0013">13</xref>), association of lactic acidosis with thyroid storm has rarely been reported (<xref ref-type="bibr" rid="CIT0003 CIT0004 CIT0005">3&#x2013;5</xref>). In our patient, all microbiological cultures were negative, and the condition improved without the administration of antibiotics. Therefore, the involvement of serious infectious disease in the etiology of our patient's condition was ruled out. Morbid conditions leading to lactic acidosis may include an increase in the rate of anaerobic metabolism caused by a decrease in the oxygen supply to the periphery as a result of decreased cardiac output and decrease in lactic acid metabolism caused by congestive hepatic failure; lactic acid is not converted into glucose due to dysfunction of the Cori cycle, resulting in worsening of lactic acidosis and development of hypoglycemia.</p>
      <p>Patients with thyroid storm usually show elevation of the body temperature, but our present patient was hypothermic (body temperature, 34.5&#xB0;C). Thyroid hormones act on the hepatic mitochondria to enhance utilization of the proton gradient for thermogenesis rather than for adenosine triphosphate (ATP) generation, which results in hyperthermia (<xref ref-type="bibr" rid="CIT0001 CIT0014">1,14</xref>). The presence of hypothermia rather than hyperthermia in the present patient suggests that there was no proton gradient available for thermogenesis, because of the circulatory failure. A previously reported patient of thyroid storm with lactic acidosis was afebrile (<xref ref-type="bibr" rid="CIT0004 CIT0005">4,5</xref>), and such an association is considered to be very serious. Hypothermia in a patient with thyroid storm indicates a very serious general condition indeed.</p>
      <p>The data from the present patient suggest that even patients with mild hyperthyroidism may develop thyroid storm in the presence of severe depression of organ functions. Prompt treatment of patients with hypothermia and lactic acidosis is essential, because these conditions are suggestive of severe thyroid storm. Our present patient showed exacerbation of circulatory failure and lactic acidosis in the course of GD but eventually survived. We therefore considered the case as worthy of being reported.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p><bold><italic>Declaration of interest:</italic></bold> We have no conflict of interests to declare in relation to submission of this manuscript. No specific grant from any funding agency in the public, commercial or not-for-profit sector was received for this research.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="CIT0001">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <collab>Wartofsky</collab>
          </person-group>
          <article-title>Thyrotoxic storm</article-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Braverman</surname>
              <given-names>LE</given-names>
            </name>
            <name>
              <surname>Utiger</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <source>Werner and Ingbar's Thyroid</source>
          <edition>9th ed</edition>
          <publisher-loc>Philadelphia</publisher-loc>
          <publisher-name>Lippincott Williams &amp; Wilkins</publisher-name>
          <year>2005</year>
          <comment>p.</comment>
          <fpage>651</fpage>
          <lpage>57</lpage>
        </element-citation>
      </ref>
      <ref id="CIT0002">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Burch</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Wartofsky</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Life-threatening thyrotoxicosis. Thyroid storm</article-title>
          <source>Endocrinol Metab Clin North Am</source>
          <year>1993</year>
          <volume>22</volume>
          <fpage>263</fpage>
          <lpage>77</lpage>
          <pub-id pub-id-type="pmid">8325286</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0003">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chong</surname>
              <given-names>HW</given-names>
            </name>
            <name>
              <surname>See</surname>
              <given-names>KC</given-names>
            </name>
            <name>
              <surname>Phua</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Thyroid storm with multiorgan failure</article-title>
          <source>Thyroid</source>
          <year>2010</year>
          <volume>20</volume>
          <fpage>333</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">20146655</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0004">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Izumi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kondo</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Okada</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>A case of atypical thyroid storm with hypoglycemia and lactic acidosis</article-title>
          <source>Endocr J</source>
          <year>2009</year>
          <volume>56</volume>
          <fpage>747</fpage>
          <lpage>52</lpage>
          <pub-id pub-id-type="pmid">19506329</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0005">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>YZ</given-names>
            </name>
            <name>
              <surname>Hutchinson</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Bartelloni</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Manthous</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>Thyroid storm presenting as multiple organ dysfunction syndrome</article-title>
          <source>Chest</source>
          <year>2000</year>
          <volume>118</volume>
          <fpage>877</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">10988222</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0006">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sherman</surname>
              <given-names>SI</given-names>
            </name>
            <name>
              <surname>Simonson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ladenson</surname>
              <given-names>PW</given-names>
            </name>
          </person-group>
          <article-title>Clinical and socioeconomic predispositions to complicated thyrotoxicosis: a predictable and preventable syndrome?</article-title>
          <source>Am J Med</source>
          <year>1996</year>
          <volume>101</volume>
          <fpage>192</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">8757360</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0007">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKenna</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Codd</surname>
              <given-names>MB</given-names>
            </name>
            <name>
              <surname>McCann</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Sugrue</surname>
              <given-names>DD</given-names>
            </name>
          </person-group>
          <article-title>Alcohol consumption and idiopathic dilated cardiomyopathy: a case control study</article-title>
          <source>Am Heart J</source>
          <year>1998</year>
          <volume>135</volume>
          <issue>(5 Pt 1)</issue>
          <fpage>833</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">9588413</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0008">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kantharia</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Richards</surname>
              <given-names>HB</given-names>
            </name>
            <name>
              <surname>Battaglia</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Reversible dilated cardiomyopathy: an unusual case of thyrotoxicosis</article-title>
          <source>Am Heart J</source>
          <year>1995</year>
          <volume>129</volume>
          <fpage>1030</fpage>
          <lpage>2</lpage>
          <pub-id pub-id-type="pmid">7732963</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0009">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ebisawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ikeda</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Murata</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sekiguchi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Yazaki</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Irreversible cardiomyopathy due to thyrotoxicosis</article-title>
          <source>Cardiology</source>
          <year>1994</year>
          <volume>84</volume>
          <fpage>274</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">8187112</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0010">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Siu</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>XH</given-names>
            </name>
            <name>
              <surname>Yung</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kung</surname>
              <given-names>AW</given-names>
            </name>
            <name>
              <surname>Lau</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Tse</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>Hemodynamic changes in hyperthyroidism-related pulmonary hypertension: a prospective echocardiographic study</article-title>
          <source>J Clin Endocrinol Metab</source>
          <year>2007</year>
          <volume>92</volume>
          <fpage>1736</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">17327384</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0011">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saunders</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Mathewkutty</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Drazner</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>McGuire</surname>
              <given-names>DK</given-names>
            </name>
          </person-group>
          <article-title>Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms</article-title>
          <source>Herz</source>
          <year>2008</year>
          <volume>33</volume>
          <fpage>184</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">18568312</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0012">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Redgrave</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Coutts</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Schulz</surname>
              <given-names>UG</given-names>
            </name>
            <name>
              <surname>Briley</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Rothwell</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Systematic review of associations between the presence of acute ischemic lesions on diffusion-weighted imaging and clinical predictors of early stroke risk after transient ischemic attack</article-title>
          <source>Stroke</source>
          <year>2007</year>
          <volume>38</volume>
          <fpage>1482</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">17379821</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0013">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Potenza</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Via</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Yanagisawa</surname>
              <given-names>RT</given-names>
            </name>
          </person-group>
          <article-title>Excess thyroid hormone and carbohydrate metabolism</article-title>
          <source>Endocr Pract</source>
          <year>2009</year>
          <volume>15</volume>
          <fpage>254</fpage>
          <lpage>62</lpage>
          <pub-id pub-id-type="pmid">19364696</pub-id>
        </element-citation>
      </ref>
      <ref id="CIT0014">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harper</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Dickinson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>MD</given-names>
            </name>
          </person-group>
          <article-title>Mitochondrial uncoupling as a target for drug development for the treatment of obesity</article-title>
          <source>Obes Rev</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>255</fpage>
          <lpage>65</lpage>
          <pub-id pub-id-type="pmid">12119996</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
